Global Hypersomnia Treatment Market Share

Market Share of Global Hypersomnia Treatment Industry

The Hypersomnia treatment market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Takeda pharmaceutical company Ltd., Teva pharmaceuticals Ltd., Jazz pharmaceuticals Ltd., Bioprojet, Avedal pharmaceuticals Plc., Pfizer Inc., Theranexus, Merck and Co., and others.

Hypersomnia Treatment Market Leaders

1. Teva pharmaceuticals Ltd.

2. Jazz pharmaceuticals Ltd.

3. Bioprojet

4. Novartis AG

5. Theranexus

*Disclaimer: Major Players sorted in no particular order